Stephen Abele
Senior Director Manufacturing and Development at Cingulate Therapeutics - Roeland Park, KS, US
Stephen Abele's Colleagues at Cingulate Therapeutics
Stephen Abele's Contact Details
913-942-2300
Morristown, New Jersey
Cingulate Therapeutics
Stephen Abele's Company Details
Cingulate® is a biopharmaceutical company utilizing its innovative Precision Timed Release™ (PTR) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. We aim to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. With an initial focus on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD), we believe there are multiple therapeutic areas where our PTR technology may be employed to develop additional product candidates, notably anxiety disorders.